News for Sankyo Co., Ltd. (6417.T)

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O N4568.T - Daiichi Sankyo Co LtdQ3 2025 Daiichi Sankyo Co Ltd Earnings PresentationJan 31, 2025

TOKYO, Jan. 30, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million1) in eight projects for the development of new diagnostics and drugs for neglected tropical diseases (NTDs) and malaria.2

Japan stocks higher at close of trade; Nikkei 225 up 1.16%

DATROWAY ® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer

Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn

Datopotamab Deruxtecan Demonstrated Meaningful Clinical Activity in Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer in TROPION-Lung05 and TROPION-Lung01 Pooled Analys

Japan stocks higher at close of trade; Nikkei 225 up 0.38%

British pharmaceutical giant AstraZeneca (AZN) has raised its annual forecast following strong demand for its cancer drugs. The company plans to invest approxim

Datopotamab Deruxtecan New BLA Submitted for Accelerated Approval in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer

Insightful Portfolio Adjustments in Q3 2024 Highlight Growth OpportunitiesThe T. Rowe Price Japan Fund (Trades, Portfolio), known for its strategic investments

Japan stocks higher at close of trade; Nikkei 225 up 0.75%

Japan stocks higher at close of trade; Nikkei 225 up 3.55%

Japan stocks higher at close of trade; Nikkei 225 up 0.06%

Japan stocks lower at close of trade; Nikkei 225 down 0.05%

In a market landscape clouded by recession fears, sell-offs and rebounds, Macquarie has identified 10 Asian stocks it believes are primed for a comeback. Amids...

Artisan International Fund's portfolio meaningfully beat the benchmark MSCI EAFE Index and the MSCI All Country World ex USA Index. Click here to read more.

Japan stocks lower at close of trade; Nikkei 225 down 2.53%